Clinical trials
Suspended Heart Failure trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ancora Heart, Inc. | 1 |
| Brigham and Women's Hospital | 1 |
| Evaheart, Inc. | 1 |
| Lenar Yessayan | 1 |
| M.D. Anderson Cancer Center | 1 |
| Mayo Clinic | 1 |
| NYU Langone Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 7 |
| Cardiomyopathies | 2 |
| Cardio-Renal Syndrome | 1 |
| Cardiomyopathy, Dilated | 1 |
| Cognitive Dysfunction | 1 |
| Coronary Artery Disease | 1 |
| Hematologic Neoplasms | 1 |
| Hypertension, Pulmonary | 1 |
| Pulmonary Embolism | 1 |
| Renal Insufficiency | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.